PharmaVOICE magazine named Nancy Berg, CEO and executive director of the International Society for Pharmacoeconomics and Outcomes Research, a 2018 PharmaVOICE 100 honoree.
Berg was honored as a “transformational leader” in the Commander and Chief rank.
She became ISPOR’s chief executive in 2014, and has since “worked closely with ISPOR’s Board of Directors to strengthen the Society and further its mission to advance HEOR excellence to improve decision making globally,” according to the release.
The society credits Berg with a number of “key strategic initiatives,” per the release, including her work with value assessment frameworks and real-world evidence efforts.
Click here to read the full report on ISPOR’s website.
For more details on the PharmaVOICE honor, click here.
